Goldfarb DA. Re: Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients with Chronic Antibody-Mediated Rejection. J Urol 2020 Aug 21:101097JU0000000000001255. doi: 10.1097/JU.0000000000001255.
PMID: 32830994